Access to needle and syringe programs and the relationship to equipment sharing among people who inject drugs in Kermanshah, Iran

References

• Bastos, F. I, & Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science & Medicine, 51(12), 1771–1782.
   PubMed Web of Science ®Google Scholar
• Binswanger, H. P. (2000). Scaling up HIV/AIDS programs to national coverage. Science, 288(5474), 2173–6.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N, Gogineni, A., Longshore, D., & Stein, M. (2001). Factors associated with readiness to change drug use among needle-exchange users. Drug and Alcohol Dependence, 62(3), 225–230.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1998). Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. JAIDS Journal of Acquired Immune Deficiency Syndromes, 18(5), 505–511.
   Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. Aids, 14(5), 605–611.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Ridgeway, G., Schell, T., Anderson, R., Flynn, N. M., & Kral, A. H. (2007). Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client‐level syringe coverage among injection drug users. Addiction, 102(4), 638–646.
   PubMed Web of Science ®Google Scholar
• Bruneau, J., Zang, G., Abrahamowicz, M., Jutras-Aswad, D., Daniel, M., & Roy, É. (2014). Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study. Clinical Infectious Diseases, 58(6), 755–761.
   PubMed Web of Science ®Google Scholar
• Bryant, J., & Treloar, C. 2006. Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. International Journal of Drug Policy, 17(5), 418–424.
   Web of Science ®Google Scholar
• Cao, W., & Treloar, C. (2006). Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug and Alcohol Review, 25(5), 439–444.
   PubMed Web of Science ®Google Scholar
• Coates, T. J., Richter, L., & Caceres, C. (2008). Behavioural strategies to reduce HIV transmission: how to make them work better. The Lancet, 372(9639), 669–684.
   PubMed Web of Science ®Google Scholar
• Corson, S., Greenhalgh, D., Taylor, A., Palmateer, N., Goldberg, D., & Hutchinson, S. (2013). Modelling the prevalence of HCV amongst people who inject drugs: An investigation into the risks associated with injecting paraphernalia sharing. Drug and Alcohol Dependence, 133(1), 172–179.
   PubMed Web of Science ®Google Scholar
• Davey-Rothwell, M. A., Latkin, C. A., & Tobin, K. E. (2010). Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia. AIDS and Behavior, 14(4), 878–884.
   PubMed Web of Science ®Google Scholar
• De, P., Cox, J., Boivin, J.-F., Platt, R. W., & Jolly, A. M. 2008. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. Journal of Urban Health, 85(1), 77–89.
   PubMed Web of Science ®Google Scholar
• Gillies, M., Palmateer, N., Hutchinson, S., Ahmed, S., Taylor, A., & Goldberg, D. (2010). The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review. BMC Public Health, 10(1), 1.
   PubMed Web of Science ®Google Scholar
• Gossop, M., Griffiths, P., Powis, B., Williamson, S., Fountain, J., & Strang, J. (1997). Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. Aids Care, 9(6), 651–660.
   PubMed Web of Science ®Google Scholar
• Islam, M. M., Wodak, A., & Conigrave, K. M. (2008). The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. International Journal of Drug Policy, 19(6), 436–441.
   PubMed Web of Science ®Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J, Wood E. (2005). Safer injection facility use and syringe sharing in injection drug users. The Lancet, 366(9482), 316–318.
   PubMed Web of Science ®Google Scholar
• Latkin, C. A, & Vlahov, D. (1998). Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users. Addiction, 93(8), 1191–1197.
   PubMed Web of Science ®Google Scholar
• Milani, H. S., Kharaghani, R., Safa, M., Samadi, R., Farhadi, M. H., Ardakani, M. R. K., et al. (2012). Pattern of smoking and nicotine dependence in patients with psychiatric disorders. Tanaffos, 11(1), 55.
   PubMedGoogle Scholar
• Mirahmadizadeh, A., Majdzadeh, R., Mohammad, K., & Forouzanfar, M. (2009). Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iranian Red Crescent Medical Journal, 11(3), 325.
   Web of Science ®Google Scholar
• Nazari, S. S. H., Noroozi, M., Soori, H., Noroozi, A., Mehrabi, Y., Hajebi, A., et al. (2015). The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. International Journal of Drug Policy. 27, 127–131.
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., et al. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet, 378(9791), 571–583.
   PubMed Web of Science ®Google Scholar
• Noroozi, A., Mirzazadeh, A., Hajebi, A., Farhoudian, A., Sharifi, H., Higgs, P., et al. (2016). Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran. Journal of Substance Use, 1–6. doi: 10.1080/14659891.2016.1195894
   Web of Science ®Google Scholar
• Noroozi, M., Mirzazadeh, A., Noroozi, A., Mehrabi, Y., Hajebi, A., & Zamani, S., et al. (2015). Client-level coverage of needle and syringe program and high-risk‎ injection behaviors: A case study of people who inject drugs in‎ Kermanshah, Iran. Addiction and Health, 7(3–4) 164.
   Google Scholar
• Noroozi, M. M., Nejat, S., Golestan, B., & Majdzadeh, R. (2012). What are differences between non-injecting and injecting drug addicts? International Journal of Preventive Medicine, 3(6), 314–319.
   Google Scholar
• Palmateer, N., Hutchinson, S., McAllister, G., Munro, A., Cameron, S., Goldberg, D., et al. (2014). Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross‐sectional survey data. Journal of Viral Hepatitis, 21(1), 25–32.
   PubMed Web of Science ®Google Scholar
• Sajadi, L., Mirzazadeh, A., Navadeh, S., Osooli, M., Khajehkazemi, R., Gouya, M. M., et al. (2013). HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010. Sexually Transmitted Infections, 89(Suppl3), iii37–iii40.
   PubMed Web of Science ®Google Scholar
• Salazar, C., & Hamidreza, S. (2006). Uniting the World Against AIDS. Iran (Islamic Republic of) UNAIDS: Joint United Nations Programme on HIV. Aids. 14(3), 879–883.
   Google Scholar
• Van Ameijden, E., & Coutinho, R. (2001). Large decline in injecting drug use in Amsterdam, 1986–1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health, 55(5), 356–363.
   PubMed Web of Science ®Google Scholar
• Vazirian, M., Nassirimanesh, B., Zamani, S., Ono-Kihara, M., Kihara, M., Ravari, S. M., et al. (2005). Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduction Journal, 2(1), 19.
   PubMedGoogle Scholar
• Wang, K., Fu, H., Longfield, K., Modi, S., Mundy, G., & Firestone, R. (2014). Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces. Harm Reduction Journal, 11, 15.
   PubMed Web of Science ®Google Scholar
• Zamani, S., Vazirian, M., Nassirimanesh, B., Razzaghi, E. M., Ono-Kihara, M., Ravari, S. M., et al. (2010). Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS and Behavior, 14(4), 885–890.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Chen, X., Zheng, J., Zhao, J., Jing, J., Zhang, J., et al. (2013). Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China. Harm Reduction Journal, 10(1), 1.
   PubMed Web of Science ®Google Scholar